Skip to main content
CI
NYSE Life Sciences

Cigna Lifts 2026 EPS Guidance to at Least $30.60 After In-Line Q3

Tom Rudovsky · Reported by dpa-AFX
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$307.26
Mkt Cap
$80.702B
52W Low
$255.528
52W High
$316.265
52W Position info
20% above low
Off High info
2.8% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CI sits 20% above its 52-week low of $255.528.

Summary

Cigna raised full-year 2026 adjusted income from operations guidance to at least $30.60 a share, up $0.15 from the prior at-least $30.45 floor, and lifted Cigna Healthcare pre-tax adjusted income guidance by $50 million to at least $4.6 billion. The quarter itself was steady rather than spectacular: adjusted income from operations of $2.1 billion, or $7.98 a share, versus $7.83 a year earlier, with growth in Cigna Healthcare and Specialty and Care Services offset by a weaker Pharmacy Benefit Services contribution. Revenue rose 6% to $73.7 billion, and adjusted revenue climbed to $73.79 billion from $69.57 billion. Reported net income fell to $1.4 billion, or $5.47 a share, from $1.9 billion, or $6.98, but that gap is the absence of last year's after-tax gain on sale, not operating deterioration. The guidance bump is small in dollar terms but it comes after the October ACA marketplace exit and trimmed insurance growth target, so it tells traders the core Evernorth and Healthcare engines are still carrying the year. Management reiterated at least 10% adjusted EPS growth for 2027 off the run-rate for ongoing businesses.

At the time of this announcement, CI was trading at $307.26 on NYSE in the Life Sciences sector, with a market capitalization of approximately $80.7B. The 52-week trading range was $255.53 to $316.27. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Nov 05, 2026, 1:00 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $302.34
Real-time Price: $275.00 info
Change: -$27.34 (-9%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 11:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $312.17
Real-time Price: $275.00 info
Change: -$37.17 (-12%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $275.00 info
Change: -$32.26 (-10%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $300.90
Real-time Price: $275.00 info
Change: -$25.90 (-9%) info
Market Cap: $71.947B info
CI
Oct 01, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $271.83
Real-time Price: $275.00 info
Change: +$3.17 (+1%) info
Market Cap: $71.947B info